Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

SHE:300401 Revenue

Zhejiang Garden Biopharmaceutical had revenue of 277.61M CNY in the quarter ending September 30, 2026, a decrease of -7.57%. This brings the company's total for the last twelve months to 1.27B, up 2.42% year-over-year. In the year 2025, Zhejiang Garden Biopharmaceutical had annual revenue of 1.24B, down -0.47%. That makes Zhejiang Garden Biopharmaceutical the 17,826th largest company in the world by revenue and 3,247th in China.

• Revenue (ttm): 1.27B
• Revenue Growth: +2.42%
• P/S Ratio: 5.11
• Revenue / Employee: 1.09M
• Employees: 1,163
• Market Cap: 6.50B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Vitamin Division 882.19M 71.2%
• Pharmaceutical Division 356.29M 28.8%

By Geography

Chart

• Foreign 636.40M 51.4%
• China 601.00M 48.6%

Fiscal year ended Dec 31, 2025 See the full SHE:300401 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.24B	-5.88M	-0.47%
Dec 31, 2024	1.24B	148.63M	13.58%
Dec 31, 2023	1.09B	-322.86M	-22.78%
Jan 1, 2023	1.42B	300.41M	26.89%
Jan 1, 2022	1.12B	457.66M	69.40%

Data Source: S&P Global Market Intelligence Last updated: Oct 19, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error